Our preliminary cases suggest the potential utility of CAIX-targeted PET/CT imaging with 68Ga-NY104 in differentiating ccRCC from benign mimickers like renal hemangioma, which warrants further prospective evaluation. The gene discussed is CA9; the disease is nonpapillary renal cell carcinoma.